D
Relmada Therapeutics, Inc. RLMD
$0.627 $0.0172.79% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -67.81M -75.71M -79.98M -86.49M -86.76M
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 22.19M 25.88M 29.81M 32.33M 36.83M
Change in Net Operating Assets -4.31M -6.95M -1.58M 952.10K 1.75M
Cash from Operations -49.92M -56.79M -51.76M -53.21M -48.18M
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 49.53M 56.86M 51.56M 47.96M 35.67M
Cash from Investing 49.53M 56.86M 51.56M 47.96M 35.67M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 0.00 0.00 246.70K 246.70K 246.70K
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -335.10K -262.10K -287.10K -213.10K -123.50K
Cash from Financing -335.10K -262.10K -40.40K 33.60K 123.20K
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -733.00K -185.40K -234.70K -5.21M -12.38M